Takeaway
- The recurrence rate is very low after breast-conserving therapy in 8485 patients treated over a 28-year period.
Study design
- This was a retrospective study of clinical characteristics, treatment, and outcome of three groups of patients (n=8485): 1980-1987, 1988-1998, and 1999-2008.
- The primary outcome measure was ipsilateral breast tumor recurrence (IBTR).
[Source:-Univadis]